Assessment of the safety of Roxadustat for cardiovascular events in chronic kidney disease-related anemia using meta-analysis and bioinformatics

• Main Authors: Xiangmeng Li (Author), Shimin Jiang (Author), Xia Gu (Author), Xiaojing Liu (Author), Shunlai Shang (Author), Jiao Zhang (Author), Keying Pang (Author), Wenge Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ObjectiveThis study compares the cardiovascular risk in anemic chronic kidney disease patients treated with Roxadustat versus erythropoietin stimulating agents (ESAs). It also explores the cardiovascular impact of Roxadustat.MethodsWe searched PubMed, EMBASE, Cochrane, Scopus, and Web of Science dat...